Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 1
2013 3
2016 2
2017 2
2018 4
2019 1
2020 3
2021 8
2022 10
2023 24
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy.
Samaei SS, Daryab M, Gholami S, Rezaee A, Fatehi N, Roshannia R, Hashemi S, Javani N, Rahmanian P, Amani-Beni R, Zandieh MA, Nabavi N, Rashidi M, Malgard N, Hashemi M, Taheriazam A. Samaei SS, et al. Among authors: nabavi n. Transl Oncol. 2024 Apr 30;45:101975. doi: 10.1016/j.tranon.2024.101975. Online ahead of print. Transl Oncol. 2024. PMID: 38692195 Free article.
Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.
Hashem M, Mohandesi Khosroshahi E, Aliahmady M, Ghanei M, Soofi Rezaie Y, Alsadat Jafari Y, Rezaei F, Khodaparast Eskadehi R, Kia Kojoori K, Jamshidian F, Nabavi N, Rashidi M, Hasani Sadi F, Taheriazam A, Entezari M. Hashem M, et al. Among authors: nabavi n. Noncoding RNA Res. 2024 Jan 22;9(2):560-582. doi: 10.1016/j.ncrna.2024.01.009. eCollection 2024 Jun. Noncoding RNA Res. 2024. PMID: 38515791 Free PMC article. Review.
Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors.
Hashemi M, Daneii P, Asadalizadeh M, Tabari K, Matinahmadi A, Bidoki SS, Motlagh YSM, Jafari AM, Ghorbani A, Dehghanpour A, Nabavi N, Tan SC, Rashidi M, Taheriazam A, Entezari M, Goharrizi MASB. Hashemi M, et al. Among authors: nabavi n. Int J Biochem Cell Biol. 2024 May;170:106566. doi: 10.1016/j.biocel.2024.106566. Epub 2024 Mar 20. Int J Biochem Cell Biol. 2024. PMID: 38513802
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
Ebrahimi N, Manavi MS, Faghihkhorasani F, Fakhr SS, Baei FJ, Khorasani FF, Zare MM, Far NP, Rezaei-Tazangi F, Ren J, Reiter RJ, Nabavi N, Aref AR, Chen C, Ertas YN, Lu Q. Ebrahimi N, et al. Among authors: nabavi n. Cancer Metastasis Rev. 2024 Mar;43(1):457-479. doi: 10.1007/s10555-023-10162-7. Epub 2024 Jan 16. Cancer Metastasis Rev. 2024. PMID: 38227149 Review.
Role of non-coding RNAs in osteoporosis.
Baniasadi M, Talebi S, Mokhtari K, Zabolian AH, Khosroshahi EM, Entezari M, Dehkhoda F, Nabavi N, Hashemi M. Baniasadi M, et al. Among authors: nabavi n. Pathol Res Pract. 2024 Jan;253:155036. doi: 10.1016/j.prp.2023.155036. Epub 2023 Dec 13. Pathol Res Pract. 2024. PMID: 38134836 Review.
EZH2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M, Nazdari N, Gholamiyan G, Paskeh MDA, Jafari AM, Nemati F, Khodaei E, Abyari G, Behdadfar N, Raei B, Raesi R, Nabavi N, Hu P, Rashidi M, Taheriazam A, Entezari M. Hashemi M, et al. Among authors: nabavi n. Pathol Res Pract. 2024 Jan;253:154988. doi: 10.1016/j.prp.2023.154988. Epub 2023 Nov 29. Pathol Res Pract. 2024. PMID: 38118215 Review.
Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer.
Hashemi M, Esbati N, Rashidi M, Gholami S, Raesi R, Bidoki SS, Goharrizi MASB, Motlagh YSM, Khorrami R, Tavakolpournegari A, Nabavi N, Zou R, Mohammadnahal L, Entezari M, Taheriazam A, Hushmandi K. Hashemi M, et al. Among authors: nabavi n. Transl Oncol. 2024 Feb;40:101846. doi: 10.1016/j.tranon.2023.101846. Epub 2023 Dec 1. Transl Oncol. 2024. PMID: 38042134 Free PMC article. Review.
miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response.
Hashemi M, Khosroshahi EM, Chegini MK, Abedi M, Matinahmadi A, Hosnarody YSD, Rezaei M, Saghari Y, Fattah E, Abdi S, Entezari M, Nabavi N, Rashidi M, Raesi R, Taheriazam A. Hashemi M, et al. Among authors: nabavi n. Pathol Res Pract. 2023 Nov;251:154906. doi: 10.1016/j.prp.2023.154906. Epub 2023 Oct 26. Pathol Res Pract. 2023. PMID: 37939448 Review.
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Bahonar A, Nakhaee Z, Entezari M, Beig Goharrizi MAS, Salimimoghadam S, Ren J, Nabavi N, Rashidi M, Dehkhoda F, Taheriazam A, Tan SC, Hushmandi K. Sadrkhanloo M, et al. Among authors: nabavi n. Pathol Res Pract. 2023 Nov;251:154902. doi: 10.1016/j.prp.2023.154902. Epub 2023 Oct 21. Pathol Res Pract. 2023. PMID: 37922723 Review.
63 results